duddingston room chairperson gerd antes
play

Duddingston Room Chairperson Gerd Antes 11.00 - 11.15 Armstrong - PowerPoint PPT Presentation

Tuesday 29 th September 2015 Location Author(s) Title Pentland Room - Chairperson - Philippe Ravaud 11.00 - 11.15 Pranic S, Marusic A Cross-sectional study of registered data and results reporting agreement in a cohort of trials in


  1. Tuesday 29 th September 2015 Location Author(s) Title Pentland Room - Chairperson - Philippe Ravaud 11.00 - 11.15 Pranic S, Marusic A Cross-sectional study of registered data and results reporting agreement in a cohort of trials in ClinicalTrials.gov 11.15 - 11.30 Chan A-W, Pello A, Kitchen J, Axentiev A, Coomes E, Liu A, Quality of dissemination from protocol approval to registration and publication: Inception cohort study of Virtanen J, Hemminki E clinical trials approved in Finland 11.30 - 11.45 Lam K, Weinberg T, Kitchen J, Chan AW Registration rates and outcome discrepancies in dermatologic trials of drug versus non-drug interventions 11.45 - 12.00 Cartabellotta A, Iacono C, Petraglia S, Pani L The fate of drugs independent research in Italy: a cross-sectional study Duddingston Room – Chairperson – Gerd Antes 11.00 - 11.15 Armstrong R, Campbell M, Craig P, Hoffman T, Development of TIDieR-PHP: a reporting guideline for social and public health interventions Katikireddi SV, Waters E 11.15 -11.30 Odutayo A, Copsey B, MacCarthy A, Chan AW, Altman DG, Registration of Clinical Trials in the United Kingdom and Hopewell S 11.30 - 11.45 Mayo-Wilson E, Grant S, Cybulski L, Montgomery P Improving transparency and reducing waste beyond biomedicine 11.45 - 12.00 Swaen G, Bouter L M, Zeegers M How waste continues after publishing – systematic review on determinants of citation bias Holyrood Room – Chairperson – Iain Chalmers 11.00 – 11.15 Borah R, Brown A, Capers P, Kaiser K The future of evidence-based medicine is not so bright: A meta-analysis of the PROSPERO systematic review registry 11.15 – 11.30 Page MJ, Shamseer L, Altman DG, Tetzlaff J, Sampson M, Epidemiology and reporting characteristics of systematic reviews: 2014 update Tricco AC, Catalá-López F et al 11.30 – 11.45 Shamseer L, Page M, Reid E, Turner L, Sampson M, Epidemiology and reporting characteristics of systematic review protocols Moher D 11.45 – 12.00 Campbell P, Enderby P, Godwin J, Langhorne P, Mead G, Reducing wasted research effort by increasing the clinical value and accessibility of systematic reviews van Wijck F, Pollock A Salisbury Room – Chairperson – Malcolm Macleod 11.00 – 11.15 Langan SM, Guttman A, Harron K, Moher D, Petersen I, Guidelines for the REporting of studies Conducted using Observational Routinely-collected health data S ǿ rensen HT et al (RECORD): An extension of the STROBE reporting guidelines 11.15 – 11.30 Young A, Thomas S Maximising the benefit from health research: adding value by closing the loop 11.30 – 11.45 Gauthier M, Ravaud P, Baron G, Dechartres A, Haneef R, Public availability of results of observational studies evaluating an intervention registered at Boutron I ClinicalTrials.gov

  2. Tuesday 29 th September 2015 Location Author(s) Title Pentland Room – Chairperson – John Ioannidis 14.00 – 14.15 MacLeod MR on behalf of the IICARus and NPQIP investigators Strategies for publishers to improve the reporting of in vivo research 14.15 – 14.30 Leenaars M, Ritskes-Hoitinga M Lessons learned from the implementation of systematic reviews in laboratory animal science 14.30 – 14.45 Holman C, Diamantaras A, Grittner U,Kimmelman J, Where Have All the Rodents Gone? The Effects of Attrition in Experimental Research on Cancer and Stroke Piper SK, Siegerink B, Dirnagl U 14.45 – 15.00 Danborg PB, Simonsen AL, Hrǿbjartsson A, Gǿtzsche PC Risk of bias assessment in preclinical research supporting clinical practice 15.00 – 15.15 Sena ES, on behalf of the MultiPART consortium Multi centre animal studies: a strategy to improve the prospects of translational success 15.15 – 15.30 Offenhauser N, Kurreck C, Dirnagl U, for the Department of From policies to standards: Implementing and managing a structured ISO 9001 certified Quality System in Experimental Neurology QM Steering Group an academic translational neuroscience research lab Duddingston Room – Chairperson – Ana Marusic 14.00 – 14.15 Galipeau J, Cobey KD, Shamseer L, Moher D The Role of Publication Officers in Increasing Value and Decreasing Waste in Biomedical Research 14.15 – 14.30 Shamseer L, Barbour V, Bell-Syer S, Cumpston M, Deeks J, Developing Core Competencies for Scientific Editors of Biomedical Journals Garner P, MacLehose H, Straus S et al 14.30 – 14.45 Callender T Reporting Carbon to Reduce Waste and Improve Efficiency – The GREENER Initiative 14.45 – 15.00 Toews I, Wolff RF, Binder N, Toprak G, von Elm E, Meerpohl JJ Editorial policies of hematology and oncology journals: A cross-sectional study of author instructions 15.00 – 15.15 The Transparency and Openness Promotion (TOP) Committee The TOP Guideline to promote transparency, openness, and reproducibility 15.15 – 15.30 Rodríguez AC Making the case for creating synergy between EQUATOR and manuscript editing companies Holyrood Room – Chairperson – Doug Altman 14.00 – 14.15 Kapadia M, Moher D, Offringa M, on BEHALF OF PRISMA- Increasing value and reducing waste in child health systematic reviews and meta-analyses - PC and PRISMA-C STEERING GROUP Protocols (PRISMA-PC) and Reporting (PRISMA-C) 14.15 – 14.30 Clyburne-Sherin A, Thurairajah P, Chan WWY, Kapadia M, SPIRIT-C: Increasing research value / reducing research waste through evidence-based reporting Moher D, Klassen T, Offringa M standards for pediatric clinical trial protocols 14.30 – 14.45 Clyburne-Sherin A, Thurairajah P, Chan WWY, Kapadia M, CONSORT-C: Increasing research value / reducing research waste through evidence-based Moher D, Chan A, Klassen T, Offringa M reporting standards for pediatric clinical trials 14.45 – 15.00 Kapadia M, Thurairajah P, Terwee C, Beaton D, Offringa New evidence and consensus based reporting Instrument for the Selection of Pediatric Endpoints M in Clinical Trials: InSPECT 15.00 – 15.15 Kelly LE, Offringa M Increasing value and reducing waste in child health research through evidence-based guidance for selecting a comparator treatment in pediatric clinical trials 15.15 – 15.30 Kapadia M, Kelly LE, Needham A, Chan W, Clyburne- Increasing value and reducing waste in child health research by developing and implementing Sherin A, Thurairajah P, Offringa M novel methodology: Enhancing Research Impact in Child Health (EnRICH) Salisbury Room – Chairperson – Gerd Antes 14.00 – 14.15 Barnett A, Clarke P, Herbert D Randomness and high cost for funding outcomes 14.15 – 14.30 Shamseer L, Moher D, Maduekwe O, Turner L, Barbour V, Comparison of characteristics potential predatory journals with subscription and open access journals. A Burch R et al cross-sectional study. 14.30 – 14.45 Olivieri J, Manfredi L, Postacchini L, Tedesco S, Leoni P, Poor adherence to methodological recommendations supports biased research results in steroid-refractory Gabriella A et al chronic Graft-versus-Host Disease: a systematic review and meta-analysis 14.45 – 15.00 Malicki M, Utrobicic A, Marusic A Addressing duplicate publications in biomedicine: a mixed method study 15.00 – 15.15 Hemminki E Improper research regulation is a cause for waste in clinical research 15.15 – 15.30 Bouter LM, Axelsen N, ter Riet G, Tijdink J Survey among experts to rank major and minor research misbehaviors

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend